X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10501) 10501
Magazine Article (43) 43
Book Chapter (13) 13
Newspaper Article (9) 9
Newsletter (4) 4
Book / eBook (3) 3
Reference (3) 3
Book Review (2) 2
Government Document (2) 2
Dissertation (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8817) 8817
female (5329) 5329
male (5077) 5077
middle aged (3296) 3296
adult (3171) 3171
anemia - chemically induced (3160) 3160
aged (2514) 2514
anemia (2288) 2288
animals (2196) 2196
anemia, hemolytic - chemically induced (1673) 1673
oncology (1356) 1356
anemia, aplastic - chemically induced (1264) 1264
hematology (1113) 1113
treatment outcome (988) 988
adolescent (934) 934
thrombocytopenia - chemically induced (823) 823
anemia - drug therapy (819) 819
antineoplastic agents - adverse effects (785) 785
child (781) 781
rats (775) 775
pharmacology & pharmacy (673) 673
antineoplastic combined chemotherapy protocols - adverse effects (670) 670
cancer (670) 670
chemotherapy (669) 669
mice (668) 668
neutropenia - chemically induced (650) 650
medicine, general & internal (648) 648
erythropoietin - therapeutic use (628) 628
aged, 80 and over (618) 618
time factors (597) 597
antineoplastic combined chemotherapy protocols - therapeutic use (595) 595
dose-response relationship, drug (581) 581
therapy (575) 575
recombinant proteins (544) 544
risk factors (527) 527
retrospective studies (499) 499
neoplasms - drug therapy (486) 486
drug administration schedule (477) 477
child, preschool (475) 475
anemia, hemolytic, autoimmune - chemically induced (457) 457
erythropoietin (457) 457
care and treatment (445) 445
leukopenia - chemically induced (431) 431
anemia - blood (430) 430
hemoglobin (429) 429
drug therapy, combination (423) 423
hematocrit (397) 397
hemoglobins - analysis (394) 394
toxicology (392) 392
anemia - etiology (390) 390
medicine & public health (384) 384
toxicity (376) 376
pregnancy (362) 362
erythropoietin - adverse effects (360) 360
hemoglobins - metabolism (360) 360
health aspects (341) 341
analysis (338) 338
research (338) 338
antineoplastic agents - therapeutic use (334) 334
blood transfusion (333) 333
infant (331) 331
chloramphenicol - adverse effects (329) 329
drug therapy (318) 318
hematinics - therapeutic use (314) 314
bone marrow - drug effects (312) 312
follow-up studies (302) 302
antiviral agents - adverse effects (293) 293
research article (293) 293
erythrocytes - drug effects (291) 291
prospective studies (291) 291
young adult (289) 289
administration, oral (288) 288
agranulocytosis - chemically induced (288) 288
urology & nephrology (279) 279
pediatrics (278) 278
immunology (275) 275
anemia, aplastic - drug therapy (274) 274
phenylhydrazines (274) 274
gastroenterology & hepatology (273) 273
recombinant-human-erythropoietin (272) 272
iron (271) 271
double-blind (264) 264
ribavirin - adverse effects (261) 261
trial (261) 261
lung neoplasms - drug therapy (259) 259
blood (257) 257
anemia, macrocytic - chemically induced (256) 256
hepatitis c, chronic - drug therapy (254) 254
erythropoietin - administration & dosage (253) 253
hematologic diseases - chemically induced (253) 253
acute disease (251) 251
erythropoiesis - drug effects (248) 248
blood cell count (242) 242
nausea - chemically induced (241) 241
hemolysis (238) 238
anemia - therapy (235) 235
epoetin alfa (234) 234
infectious diseases (231) 231
thrombocytopenia (230) 230
hemolytic anemia (228) 228
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9054) 9054
German (369) 369
French (295) 295
Japanese (263) 263
Spanish (164) 164
Russian (151) 151
Italian (113) 113
Polish (88) 88
Chinese (67) 67
Dutch (30) 30
Danish (20) 20
Hungarian (20) 20
Romanian (18) 18
Norwegian (15) 15
Czech (14) 14
Hebrew (14) 14
Portuguese (13) 13
Swedish (13) 13
Bulgarian (7) 7
Finnish (7) 7
Serbian (7) 7
Ukrainian (7) 7
Croatian (6) 6
Afrikaans (2) 2
Slovak (2) 2
Turkish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 153 - 163
Journal Article
The Lancet. Haematology, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Infections - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 770 - 778
Summary Background Pancreatic cancer statistics are dismal, with a 5-year survival of less than 10%, and more than 50% of patients presenting with metastatic... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | MITOCHONDRIAL METABOLISM | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Sulfides - administration & dosage | Pancreatic Neoplasms - drug therapy | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Hyperglycemia - chemically induced | Leucovorin - adverse effects | Fluorouracil - adverse effects | Hypokalemia - chemically induced | Camptothecin - administration & dosage | Female | Neutropenia - chemically induced | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Hematologic Diseases - chemically induced | Sensation Disorders - chemically induced | Abdominal Pain - chemically induced | Pancreatic Neoplasms - pathology | Anemia - chemically induced | Thrombocytopenia - chemically induced | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Hypoalbuminemia - chemically induced | Maximum Tolerated Dose | Sepsis - chemically induced | Sulfides - adverse effects | Aged | Caprylates - administration & dosage | Caprylates - adverse effects | Organoplatinum Compounds - adverse effects | Lymphopenia - chemically induced | Enzymes | Medical colleges | Care and treatment | Metastasis | Antineoplastic agents | Cells | Antimitotic agents | Cancer patients | Chemotherapy | Pancreatic cancer | Physiological aspects | Product development | Cancer
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2012, Volume 87, Issue 8, pp. 732 - 738
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2014, Volume 32, Issue 2, pp. 76 - 82
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 7, pp. 946 - 957
Summary Background Outcomes for children with relapsed and refractory neuroblastoma are dismal. The combination of irinotecan and temozolomide has activity in... 
Hematology, Oncology and Palliative Medicine | Dacarbazine - adverse effects | Humans | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | N-Myc Proto-Oncogene Protein - genetics | Neoplasm Recurrence, Local - drug therapy | Infant | Response Evaluation Criteria in Solid Tumors | Alanine Transaminase - blood | Pain - chemically induced | Fever - chemically induced | Infection - chemically induced | Ganglioneuroblastoma - diagnostic imaging | Neoplasm Recurrence, Local - diagnostic imaging | Hypokalemia - chemically induced | Dacarbazine - analogs & derivatives | Camptothecin - administration & dosage | Ganglioneuroblastoma - drug therapy | Neutropenia - chemically induced | Child | Sirolimus - adverse effects | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Dacarbazine - administration & dosage | Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage | Sirolimus - analogs & derivatives | Ganglioneuroblastoma - genetics | Neuroblastoma - genetics | Anemia - chemically induced | Neuroblastoma - diagnostic imaging | Survival Rate | Thrombocytopenia - chemically induced | Disease-Free Survival | Retreatment | Sirolimus - administration & dosage | Gene Amplification | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neuroblastoma - drug therapy | Adolescent | Neoplasm Recurrence, Local - genetics | Hypoxia - chemically induced | Medical colleges | Stem cells | Neuroblastoma
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 200 - 211
Journal Article
British Journal of Cancer, ISSN 0007-0920, 09/2017, Volume 117, Issue 7, pp. 938 - 946
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 640 - 653
Summary Background Although trastuzumab plus chemotherapy is the standard of care for first-line treatment of HER2-positive advanced gastric cancer, there is... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | SUPPORTIVE CARE | WEEKLY PACLITAXEL | ONCOLOGY | 2ND-LINE CHEMOTHERAPY | IRINOTECAN | LEVEL | PLUS PACLITAXEL | HER2 | CANCER | DOCETAXEL | Follow-Up Studies | Febrile Neutropenia - chemically induced | Humans | Middle Aged | Male | Stomach Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Taxoids - therapeutic use | Antineoplastic Agents - adverse effects | Pneumonia - chemically induced | Aged, 80 and over | Adult | Female | Stomach Neoplasms - chemistry | Adenocarcinoma - chemistry | Taxoids - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Maytansine - adverse effects | Bridged-Ring Compounds - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Maytansine - analogs & derivatives | Anemia - chemically induced | Survival Rate | Thrombocytopenia - chemically induced | Stomach Neoplasms - drug therapy | Maytansine - therapeutic use | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Esophagogastric Junction | Gastrointestinal Hemorrhage - chemically induced | Retreatment | Intention to Treat Analysis | Bridged-Ring Compounds - adverse effects | Aged | Receptor, ErbB-2 - analysis | Trastuzumab | Adenocarcinoma | Medical research | Chemotherapy | Clinical trials | Medicine, Experimental | Metastasis | Esophageal cancer | Cancer | Analysis
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 27 - 38
Journal Article